Nextcure, inc. (NXTC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Revenue:
Revenue

22,378

2,005

1,583

1,402

1,357

-

-

-

-

Operating expenses:
Research and development

10,578

11,397

8,663

7,643

6,513

6,248

4,895

4,434

4,210

General and administrative

3,588

2,618

2,622

2,714

1,659

819

925

866

799

Total operating expenses

14,166

14,015

11,285

10,357

8,172

7,067

5,820

5,300

5,009

Income (loss) from operations

8,212

-12,010

-9,702

-8,955

-6,815

-7,067

-5,820

-5,300

-5,009

Other income, net

1,521

1,083

1,268

734

660

205

110

69

13

Net income (loss)

9,733

-10,927

-8,434

-8,221

-6,155

-6,862

-5,710

-5,231

-4,996

Earnings (loss) per share
Basic (in dollars per share)

0.35

-

-

-

-4.46

-

-

-

-

Diluted (in dollars per share)

0.33

-

-

-

-4.46

-

-

-

-

Shares used in the calculation of earnings (loss) per share
Basic (in shares)

27,506

-

-

-

1,379

-

-

-

-

Diluted (in shares)

29,348

-

-

-

1,379

-

-

-

-

Net loss per common share—basic and diluted (in dollars per share)

-

-

-0.37

-0.61

-

-5.00

-4.17

-3.82

-3.65

Weighted average number of common shares —basic and diluted (in shares)

-

-

22,715

13,498

-

1,371

1,369

1,369

1,369

Comprehensive income (loss):
Net income (loss)

9,733

-

-

-

-6,155

-

-

-

-

Unrealized loss on marketable securities

-543

-

-58

-

-

-

-

-

-

Total comprehensive income (loss)

9,190

-

-8,492

-

-6,155

-

-5,710

-

-